Last:
Change: Change(%):
Volume: Open:
High: Low:
52Wk High: 52Wk Low:

Aclaris Therapeutics Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation.